Health executives grapple with the potential and risks of artificial intelligence (AI) and generative AI (GenAI) in healthcare, as highlighted by the EY CEO Outlook Pulse survey. The survey reveals that 66% of global healthcare CEOs recognize the need for more efforts in addressing the social, ethical, and criminal risks associated with the adoption of AI. Interviews with healthcare leaders emphasize the importance of governance and skill development to balance the potential rewards and risks. The integration of GenAI, capable of working with unstructured data, holds promise in providing critical insights for improving patient care, preventing health crises, and enhancing overall quality of care.
Wearables and real-time biometric data collection enable some health systems to apply AI for monitoring patients and identifying meaningful trends early on. However, the article emphasizes the necessity of robust governance, transparency, and continuous monitoring to ensure secure, responsible, and sustainable AI implementation in healthcare, addressing concerns related to privacy, bias, and trust. Executives are urged to focus on building scalable infrastructure, investing in AI education for healthcare providers, and strategically selecting use cases aligned with organizational objectives to ensure the successful integration of AI in the evolving healthcare landscape.
